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Title: Patterns of cocaine and opioid co-use and polyroutes of administration among street-based cocaine users in 
Montréal, Canada 
Background: Effective public health programs aimed at problematic cocaine users are challenged by the fact that 
they can have complex patterns of drug use with respect to polysubstance use and routes of drug administration. This 
study was carried out to explore the presence of subgroups of cocaine users on the basis of their concurrent use of 
opioids and their routes of cocaine and opioid administration, and to determine if subgroups could be differentiated in 
terms of sociodemographic factors and risk behaviours. 
Methods: Regular cocaine users (≥ 1 per week) were recruited in low-threshold services located in the Montréal 
downtown area. The following variables were examined: demographic characteristics, types of drug used, routes of 
drug administration, and condom use with occasional or commercial sexual partners. Latent class analysis and 
multinomial logistic regression modeling were carried out. 
Results: 886 cocaine users were recruited (83.5% male: mean age 35.38 years). A 5-class model was identified: 1) 
“Cocaine Smokers” (CSs) (n = 161; membership probability (MP) = 0.183); 2) “Cocaine Smokers/Sniffers” (CSSs) (n 
= 201; MP = 0.218); “Cocaine Injectors” (CIs) (n = 207; MP = 0.231); 4) “Cocaine-Opioid Injectors” (COIs) (n = 
277; MP = 0.291); and 5) “Cocaine-Opioid Polyroute users” (COPs) (n = 40; MP = 0.077). Compared with COIs, 
other subtypes were significantly different in terms of either age, duration of cocaine use, ethnic background, 
homelessness, polydrug use or condom use. 
Conclusion: The heterogeneity of consumption patterns supports the importance of offering an array of interventions 
aimed at problematic cocaine users. These should include the provision of clean injecting and smoking material, the 
promotion of safe sexual behaviours and the prevention of initiation to drug injection. In the absence of specific 
treatment, cocaine users should have access to primary health care services and addiction treatment based on 
innovative behavioral and pharmacological approaches. 
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INTRODUCTION 
Problematic cocaine use (used by injection or involving dependence) (UNODC, 2011a) is a major public 
health concern in several countries of the world, especially in North America (UNODC, 2001b) where it plays a major 
role in the HIV and HCV epidemics (Edlin et al., 1994; Nelson et al., 2002; Patrick et al., 2001; Tyndall et al., 2003; 
Bruneau, Roy, Arruda, Zang & Jutras-Aswad, 2012; Roy et al., 2012). The development of public health programs 
aimed at problematic cocaine users is challenged by the fact that they can have complex patterns of drug use, 
particularly with respect to polysubstance use and routes of drug administration (Fischer et al., 2010; Guindalini, 
Vallada, Breen, & Laranjeira, 2006; Latkin, Knowlton, & Sherman, 2001; Prinzleve et al., 2004; Roy, Arruda, 
Vaillancourt, et al., 2012; Shaw, Shah, Jolly, & Wylie, 2008). 
Cocaine and heroin co-use is noticeably associated with the use of multiple routes of drug administration 
including drug injection (Latkin, et al., 2001; Monga et al., 2007; Kuramoto, Bonhert, & Latkin, 2011; Roy, Arruda, 
Vaillancourt, et al. 2012). Cocaine injection with or without opioid co-use, is demonstrated to be associated with 
erratic drug use practices and increase risk of HIV and HCV transmission (Bourgois & Bruneau, 2000; Patrick et al., 
2001; Tyndall et al., 2003). Recent evidence suggests a synergistic effect of cocaine and heroin injection on HCV risk 
(Bruneau et al., 2012). Crack smoking has also been found to increase risks of HIV and HCV infections, mainly via 
increased unsafe sexual behaviours and multiperson use of crack-smoking implements (Booth, Watter, & Chitwood, 
1993; Booth, Kwiatkowski, & Chitwood, 2000; Harzke, Williams, & Bowen, 2009; Inciardi, 1995; Jones et al., 1998; 
Schönnesson et al., 2008; Tortu, McMahon, Pouget, & Hamid, 2004). 
The consumption of more than one substance on a short period of time or concurrently (polysubstance use), 
especially the combined use of opioids and cocaine, is also an important issue when it comes to addiction and health 
services for drug users (Fischer et al., 2006; Léri, Stewart, Tremblay, & Bruneau, 2004; Léri et al., 2005; Roy, Arruda, 
Vaillancourt, et al., 2012). For instance, co-use of stimulants and opioids significantly contributes to fatal and non-
fatal overdoses, resulting in high morbidity and mortality rates among polydrug users (Coffin et al., 2003; Davidson et 
al., 2003; Ochoa, Hahn, Seal, & Moss, 2001). Moreover, effective treatment programs, with positive long-term effects 
are not yet available for problematic cocaine users (de Lima, de Oliveira Soares, Perreira Reisser, & Farrell, 2002). 
While substitution therapy programs, high- and low-threshold, have shown very positive outcomes for opioid users 
(Farré, Mas, Torrens, Moreno, & Cami, 2002; Fareed, Vayalapalli, Casarella, Amar, & Drexler, 2010; Marsch, 1998) 
an analogous option for problematic cocaine users has yet to emerge. Opioid substitution treatment (OST) has no 
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direct effect on cocaine use, which in turn has a deleterious effect on treatment outcome for opioid dependence 
(Sullivan et al., 2010; Williamson, Darke, Ross, & Teeson, 2006). 
Little is known about specific combinations of substances and routes of administration in populations of 
problematic cocaine users. Latent class analysis (LCA) (McCutcheon, 1987) has been recently used in a few studies to 
examine subtypes of problematic drug users given their specific patterns of drug use and routes of drug administration 
(Kuramoto et al., 2011; Patra, Fischer, Maksimowska, & Rehm, 2009). One study carried out in USA found five 
patterns in a sample of inner-city users of heroin and cocaine, with three subgroups of IDUs (heroin injecting, 
polydrug and polyroute, and heroin and cocaine injecting) and two with low proportions of IDUs (heroin snorting and 
crack smoking) (Kuramoto et al., 2011). In a Canadian study carried out among regular street-based opioid users, the 
analysis resulted in a typology of eight types of users characterized both by the distinct relative prevalence of different 
substances, mostly stimulants and opioids, and the presence or absence of injection as the primary route of 
administration (Patra et al., 2009). 
Although studies demonstrated high rates of opioid use and injection among problematic cocaine users (Roy, 
Arruda, Vaillancourt, et al., 2012; Prinzleve et al., 2004), no study so far has specifically examined drug use sub-types 
in relation to opioid co-use among problematic cocaine users. Understanding differences between patterns of use 
among problematic cocaine users is of paramount importance to better control HIV and HCV transmission. We 
carried out this study with the aim of improving intervention programs designed for problematic cocaine users. The 
main objective of this analysis was to explore the presence of subgroups of cocaine users on the basis of their 
concurrent use of opioids, including heroin and POs, and their routes of cocaine and opioid administration. A 
secondary objective was to determine if subgroups could be differentiated in terms of sociodemographic factors and 
drug use and sexual behaviours. 
 
METHODS 
Study design and participants 
The study used a cross-sectional design. Regular cocaine users were recruited by trained interviewers in 
community-based low-threshold programs located in downtown Montréal. These programs offer services such as 
provision of clean drug injection and smoking paraphernalia, and various primary health care and social services. 
Eligibility criteria were 1) being aged 14 or older, 2) speaking French or English, and 3) having used cocaine on a 
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regular basis, that is, once a week or more in the past month. After signing a consent form, eligible cocaine users 
completed an interviewer-administered questionnaire lasting approximately 60 minutes. They received a monetary 
stipend of CAN$20 for their participation. Ethical approval was provided by Le comité d’éthique de la recherche en 
santé chez l’humain du CHUS et de l’Université de Sherbrooke. 
 
Study variables and measures 
To examine subgroups of problematic cocaine users, types of drugs used and routes of administration were 
assessed. Participants were asked if they had used cocaine, heroin, cannabis, amphetamines, speedball, phencyclidine 
(PCP) or other substances. The non-medical use of hydromorphone (either Dilaudid® or Hydromorph Contin®) was 
also specifically assessed since this type of PO is the one most frequently used by street-based drug users in East-
Central Canada (Parent et al., 2009). Participants who reported using other POs (included in the ‘other drug’ category) 
were also classified as using POs. These POs were Empracet®, Fentanyl®, methadone, morphine, Oxycontin®, 
Statex®, and Supeudol®. Routes of administration—including injected, smoked, snorted, eaten and/or drank—were 
examined for each drug. 
To determine if subgroups could be differentiated in terms of sociodemographic factors and risk behaviours, 
a second set of analyses was carried out on the whole sample, including all participants whether they injected drugs or 
not. The following variables were considered: age, sex, ethnic background (based on the country of birth of at least 
one parent (Canada or other), residential status, polydrug use, duration of cocaine use and condom use. Participants 
who resided most of the time in a hotel/motel room, a shelter or on the street were considered homeless. Polydrug use 
was defined as using three or more drugs, excluding heroin and POs, which allowed exploration of associations 
between polydrug use and subgroups of cocaine users beyond cocaine and opioid co-use. Participants were considered 
as having risky sexual practices if they reported never or only sometimes using a condom for oral, anal or vaginal sex 
with occasional or commercial sexual partners. All questions regarding behaviours focused on the month preceding 
the interview. 
 
Analyses strategy 
Latent class analysis (LCA) (McCutcheon, 1987) has been used previously to examine subtypes of drug users 
given their specific patterns of drug use and routes of drug administration (Kuramoto et al., 2011, Monga et al., 2007; 
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Patra, et al., 2009). For this study, LCA was used to identify subgroups of street-based cocaine users with similar past-
month patterns of cocaine and opioid (PO and heroin) consumption, and routes of administration. The analysis was 
applied to seven dichotomous variables (past-month injected cocaine, smoked cocaine, snorted cocaine, injected 
heroin [including speedball], non-injected heroin, injected POs and non-injected POs) to determine the more limited 
number of emerging subgroups of cocaine users. The best number of latent classes was determined using the bootstrap 
likelihood ratio test (BLRT), as suggested by Nylund, Asparouhov, and Muthén (2007). This test compares the overall 
fit between a model with k-1 class and a model with k class. If the p-value is smaller than 0.05 then using a k class 
model rather than a k-1 class model significantly improves the fit. The model selection was also based on the 
Adjusted Bayesian Information Criterion (ABIC), where a lower value indicates a better fit. The maximum likelihood 
method was carried out to estimate models, and different starting values were used to avoid local maxima. The 
assumption of local independence was verified using bivariate residuals (Magidson & Vermunt, 2007). Participants 
were assigned to classes based on the posterior probabilities of class membership given drug use behaviours. LCA 
was performed using MPlus version 6.1 (Muthén & Muthén, 2010). Emerging subgroups were compared based on 
sociodemographics, drug use patterns and risky sexual practices by means of Chi-square tests for categorical 
variables. 
A multinomial logistic regression analysis was carried out to explore the correlates of subgroups emerging 
from the LCA. Class membership was the dependent variable. The following independent variables were entered into 
the model: age (≤ 24 vs. > 24), ethnic background (both parents born in Canada vs. at least one parent born outside 
Canada), homelessness (yes/no), duration of cocaine consumption (continuous value), polydrug use (≥ 3 excluding 
heroin and PO), and risky sexual practices (yes/no). All variables associated with class membership at a p-value of 
0.20 in bivariate analyses were considered in the full model. The purposeful selection method (Hosmer & Lemeshow, 
2000) was used to select variables. After verification of potential confounders, variables were retained in the final 
model using a significance threshold of less than 0.05. Analyses were performed with PASW 18. 
 
RESULTS 
A total of 886 cocaine users were recruited between June 2008 and October 2010 (Table 1). Men comprised 
83.5% of the sample and mean age of participants was 35.4 years old. On average, participants had been using cocaine 
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for 18.17 years. Only 15.1% of participants had one parent born outside Canada and 40.4% of participants had 
experienced homelessness in the preceding month. 
More than 50% of participants reported cocaine as the drug most frequently used (52%), followed by 
cannabis (26.1%), POs (11.9%), heroin (7.1%), and amphetamines (2.4%). Polydrug use, beyond cocaine and opioid 
co-use, was also frequent (41.5%). Regarding past-month routes of cocaine administration, 86.5% reported smoking 
the drug, 61.2% injecting it, and 37% snorting it. More than half of participants reported past-month opioid use, while 
40.3% had used POs, 36.3% heroin, and 11.5% speedball (a mixture of heroin and cocaine). 
 
INSERT TABLE 1 
 
Class membership 
Based on the BLRT, the 5-class model was selected over the 4-class (p < 0.001) and the 6-class (BLRT; 
p=0.42) models. Furthermore, the 5-class model had the lowest ABIC (5880.43) and highest entropy (0.89), and met 
the local independence assumption since none of its bivariate residuals were significant. Table 2 presents the 5-class 
solution as well as each class membership probability, and probabilities of substance use and route of drug 
administration, given class membership. Results showed that the probability of smoking cocaine was high for each 
class. Emerging cocaine user subgroups were named according to their specific pattern of drug use and routes of drug 
administration. Classes 1 and 2 were characterized by minimal cocaine and opioid co-use and low proportion of IDUs. 
The Cocaine Smokers (CSs) (class 1; membership probability = 0.183) was characterised by a 100% probability (or 1) 
of smoking cocaine. Probabilities of using opioids and using routes of intake other than smoking were low. The 
Cocaine Sniffers/Smokers (CSSs) subgroup (class 2; membership probability = 0.218) was primarily composed of 
cocaine users whose routes of administration were mainly snorting and smoking. The Cocaine Injectors (CIs) 
subgroup (class 3; membership probability = 0.231) was comprised mostly of cocaine users with a 100% probability 
of injecting cocaine, a lower but elevated probability of smoking cocaine (0.675), and a moderate probability of heroin 
injection (0.291). The Cocaine-Opioid Injectors (COIs) subgroup (class 4; membership probability = 0.291) 
represented the largest group of the sample, with users exhibiting 100% probability of injecting POs, a high 
probability of injecting and smoking cocaine, and of injecting heroin (0.672). Finally the Cocaine-Opioid Polyroutes 
(COPs) subgroup (class 5; membership probability =0.077), the smallest one, was characterised by cocaine and opioid 
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co-use including heroin and POs and polyroutes of drug administration. Probabilities of smoking cocaine and 
injecting cocaine, heroin and POs were high. Furthermore, COPs had moderate probabilities of snorting cocaine and 
using heroin by routes other than injection. COPs also presented the highest probability of PO consumption by various 
routes of intake. 
 
INSERT TABLE 2 
 
Sociodemographic and behavioural characteristics of the subgroups 
Table 3 presents the sociodemographic characteristics and behavioural patterns of the five subgroups. CSs 
and CSSs presented the highest percentages of participants aged 24 and younger (24.8% and 38.8%) while CIs were 
older, with more than 92% of participants over 24 years of age. CIs reported the longest duration of cocaine use with 
an average of 21.83 years while CSSs had the shortest with an average of 14.99 years. COPs and CSSs had the most 
diverse ethnic backgrounds followed by CSs. COIs and COPs presented the least stable housing status while CIs 
reported the most stable one. 
Regarding types of drugs most frequently used, CIs were the most numerous to report using mostly cocaine 
(70%). CSs and CSSs mainly used cocaine (59.6% and 50.2%), followed by cannabis (36 % and 41.3%), and 
amphetamines in a smaller proportion. COIs and COPs were the most numerous to use mainly opioids (46.4% and 
25.0%). POs were particularly popular among COIs (34.4%) and COPs (15%). 
Results underscore the presence of three types of opioid users: minimal users (CSs and CSSs), low users 
(CIs), and high users (COIs and COPs), the last type being the subgroup for which the “co-user” label is most 
appropriate. Although a low percentage of study participants used speedball, a significant proportion of co-users did 
so (COIs = 24.5%; COPs = 37.5%). 
 
INSERT TABLE 3 
 
Results revealed a high percentage (52.4%) of cocaine and opioid co-use among study participants, with 
COIs being the largest subgroup of co-users in the sample. Therefore, a multivariate analysis comparing each 
subgroup to COIs was carried out (Table 4). Compared to COIs, CSs were more likely to have at least one parent born 
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outside Canada (adjusted odds ratio [AOR] = 1.79) and to engage in riskier sexual practices (AOR = 1.89). They were 
less likely to be over 24 years old (AOR = 0.35) and to be polydrug users (AOR=0.41). For their part, CSSs were 
more likely than COIs to have at least one parent born outside Canada (AOR = 2.06) and to report high-risk sexual 
practices (AOR=1.81). However, they were less likely to be older than 24 years (AOR=0.20) and homeless 
(AOR=0.62). Compared to COIs, cocaine injectors (CI) were less likely to be homeless (AOR=0.54) and polydrug 
users (AOR=0.23). Even after controlling for age, CIs were also more likely to have used cocaine for a longer period 
of time (AOR = 1.04). Finally, COPs were more likely to have at least one parent born outside Canada (AOR = 2.52) 
and to be polydrug users (AOR=2.41), compared to COIs. 
 
INSERT TABLE 4 
 
DISCUSSION 
This study is the first to explore the presence of subgroups of regular cocaine users with respect to their 
concomitant use of opioids and routes of drug administration. Like other studies conducted in Canada and the United 
States, we observed that cocaine and opioid co-use is common among problematic drug users. (Harrell, Mancha, 
Petras, Trenz, & Latimer, 2012; Kuramoto et al., 2011; Léri et al., 2005; Monga et al., 2007; Patra et al., 2009). In this 
study, a significant number of cocaine users consumed few or no opioids. Some almost exclusively inhaled cocaine 
(CSs) while others were more likely to combine smoking and other routes of drug administration like snorting (CSSs) 
or injecting (CIs). Also, about half of study participants used both cocaine and opioids, including a significant 
proportion of POs. This result possibly reflects the increase of non-medical use of POs observed in North America 
(Compton & Volkow, 2006; McCarthy, 2007; UNODC, 2010). Furthermore, cocaine users who inject the drug were 
more likely to use opioids, with a subgroup (COIs) injecting mostly POs and, in a smaller proportion, heroin; another 
subgroup (COPs) consumed both types of drugs through various routes of administration. It is worth stressing that 
very few users reported consuming POs by means other than injection.  
Simultaneous use of cocaine and opioids, as measured by speedball use, was relatively low among study 
participants (11.5%) although higher proportions were observed among COIs (24.5%) and COPs (37.5%). Co-use of 
cocaine and opioids seemed to be more of the sequential type. In a review paper on cocaine and opioid co-use, Léri, 
Bruneau, and Stewart (2003) described a group of sequential co-users as being heavy cocaine users seeking the 
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depressant effect of heroin to deal with the state of over-excitability produced by frequent cocaine use. Though these 
users are not necessarily addicted to opioids, addiction could eventually develop. This profile could correspond to 
many of this study’s co-users, especially CIs and COPs, subgroups with few participants reporting opioids as the drug 
most frequently used. Among COIs, the situation is slightly different since almost half reported opioids as being the 
drug most frequently used (12.0% heroin; 34.4% PO). This profile may correspond, at least partially, to another group 
described by Léri et al. (2003), one composed of opioid-dependent users who consume cocaine to reduce withdrawal 
symptoms. Also, COIs might use cocaine to counteract the physical depressive effects of opioids (Roy, Arruda, 
Vaillancourt, et al., 2012). 
Beyond pharmacological explanations, there may be structural factors underlying cocaine and opioid co-use. 
In an attempt to understand heroin initiation in the age of crack use in the United States, Chitwood, Comerford, and 
Weatherby (1998) observed that in the 1990s, changes in heroin production and distribution and in selling strategies at 
the street level produced favourable conditions to initiation of heroin use by cocaine users in that country. In Canada, 
recent studies indicate an increasing availability and accessibility of POs on the streets (Firestone & Fischer, 2008; 
Fischer, Rehm, Patra, & Firestone Cruz, 2006; Roy, Arruda, & Bourgois, 2011; Roy, Arruda, Vaillancourt, et al., 
2012). In downtown Montréal, it is easy to find and access POs for non-medical use. Most of the time, one can buy 
straight from individuals selling their own prescriptions or POs they have bought themselves on the street (Roy et al., 
2011). This increased availability of POs, in a neighbourhood where most street-based cocaine users’ activities take 
place, may have contributed to the initiation and/or maintenance of opioid use among some cocaine users. 
Based on regression analyses, two important individual factors—ethnic background and age—distinguish the 
study users’ profiles. Compared to COIs, CSs, CSSs and COPs were less likely to be of Canadian ethnic background. 
Other studies have shown ethnic differences regarding types of drugs used and routes of administration. There could 
be many explanations for these differences, including genetic differences, cultural attributes, and social structural 
factors (Agar & Reisinger, 2001; Bourgois et al., 2006; Broz & Ouellet, 2008; Ojeda, Patterson, & Strathdee, 2008; 
Vega & Gil, 1998). An in-depth examination of such factors is beyond the scope of the present study, but these 
results, in light of previous ones, deserve further investigation. 
CSs and CSSs, who represent two distinct subgroups with minimal co-use and injection drug use, were found 
to be younger than COIs even after controlling for duration of cocaine use. While this finding could reflect 
generational differences (Broz & Ouellet, 2008; Gamella, 1994; Golub & Johnson, 1999; Golub, Johnson, & Dunlap, 
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2005; Van Ameijden & Coutinho, 2001) with new users choosing other modes of drug administration than injection, 
these results are not necessarily reassuring given that crack smoking has been shown to increase the risk of initiation 
to drug injection (Irwin et al., 1996; Roy et al., 2003, 2006; Sherman et al., 2005). Young cocaine users who keep 
consuming, might also evolve towards more intense use, similar to the one observed among older study participants. 
Our findings show heterogeneity among older users in terms of drug use patterns. Though their cocaine use 
was as intense as that of COIs, the number of CIs using opioids and other drugs was lower. On the other hand, 
compared to COIs, there was a larger number of polydrug users among COPs. In other words, CIs could be described 
as pure cocaine users while COPs would be more versatile both in substances used and routes of administration. 
CSs and CSSs, who mainly smoke cocaine, were found to be more likely than COIs to have unprotected sex 
with occasional and commercial partners. This result is consistent with an extensive body of literature documenting 
the link between crack use and high-risk sexual practices, (Booth et al., 2000; Edlin et al., 1994; Harzke et al., 2009; 
Hudgins, McCusker, & Stoddard, 1995; Inciardi, 1995) sexually transmitted infections (McCoy, Lai, Metsch, 
Messiah, & Zhao, 2004; Ross, Hwang, Zack, Bull, & William, 2002), and HIV infection (DeBeck et al., 2009). 
Pharmacological effects of crack cocaine, including intense euphoria, reduction of inhibition and enhanced sexual 
sensations, appear to lead some users to engage in high-risk sexuality (Léonard & Ben Amar, 2002; McCoy & 
Inciardi, 1995). 
Finally, study findings suggest differential links between housing status and subgroups of cocaine users. Both 
CSSs and CIs were less likely to be homeless than COIs, who exhibited the highest proportion of co-use including PO 
use. Similar results suggesting an increased risk of homelessness among co-users have been observed among diverse 
drug user populations, both in Canada and the United States (Kuramoto et al., 2011; Patra et al., 2009). This finding 
may be explained by the financial pressures associated with dual dependence on cocaine and opioids that lead to a 
more precarious residential status. The analyses also showed that CSs did not differ from COIs in terms of 
homelessness. CSs represent the subgroup with the highest percentage of cocaine smoking. This finding is consistent 
with previous studies conducted elsewhere showing a link between crack use and unstable housing (Fischer et al., 
2006, 2010; Palepu, Marshall, Lai, Wood, & Kerr, 2010; Rachlis, Wood, Zhang, Montaner, & Kerr, 2009), although 
the differential effect of crack smoking and cocaine injection is not clear. 
This study presents some limitations. First, the results are not generalizable to all cocaine users since 
recruitment took place in community-based low-threshold programs usually attended by more problematic users. 
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Although the study used a convenience sample, we are quite confident that it is representative of the study population, 
especially judging by the sample’s sociodemographic characteristics, which are similar to those of cocaine users 
attending low-threshold programs in downtown Montréal (Parent et al., 2009). Second, this study relied on self-
reported information, which may be subject to social desirability and recall biases. However, evidence shows that 
drug users’ self-reports of drug use behaviours are generally valid and reliable (Darke, 1998). 
 
Implications for intervention 
Our results support the importance of offering an array of interventions that address the various needs of 
problematic cocaine users. Because drug injection was highly prevalent in our sample, the sustainability of harm 
reduction programmes aimed at IDUs is of great importance. Different substances and forms of substances are known 
to generate different injection practices and techniques. In this regard, cocaine injection, which three of our subgroups 
exhibited high probabilities (CI, COI, COP), is characterized by multiple injections in a short period of time. Optimal 
levels of harm reduction programmes implementation and coverage is critical in order to insure that sufficient sterile 
injection equipment is available to all injectors. As for PO injection, our recent work carried out in Montréal showed 
that the logistical aspects of the injection process could raise the risk of injection equipment being contaminated with 
blood, leading to increased risks of HCV seroconversion (Roy et al., 2011; Bruneau et al., 2012). This is especially 
worrisome for the COI and COP subgroups that had high probabilities of injecting POs. New intervention strategies 
and messages should be developed to counter the harms related to PO injection. More specifically, we believe that the 
sterile injection equipment distributed through harm reduction programmes is poorly adapted to the constraints of 
capsules or tablets injection. There is a need to constantly reassess and update the equipment based on the evolving 
and diverse nature of substances used.  
Specific interventions promoting safe sexual behaviours and aimed particularly at CSs and CSSs should be 
developed in order to reduce sexual transmission of HIV and other sexually transmitted infections. Also, in order to 
minimize the risks of HCV transmission through the multiperson use of crack-smoking implements, crack smoking 
materials should be made available and easily accessible. Furthermore, since there is a high risk that people who use 
crack but have never injected drugs initiate injection of cocaine or opioids (Irwin et al., 1996; Roy et al., 2003, 2006; 
Sherman et al., 2005), intervention programs designed to prevent initiation into drug injection should be implemented 
and their sustainability guaranteed. This is critical, particularly in the context of the growing popularity of POs. 
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Conversely, route transition interventions that enable injectors to change their routes of administration to less risky 
methods should be available. Although innovative projects have been developed in Montréal and elsewhere (Des 
Jarlais, Casriel, Friedman, & Rosenblum, 1992; Hunt, Stillwell, Taylor, & Griffiths, 1998; Pizzey & Hunt, 2008; Roy 
et al., 2007), their viability has yet to be secured. 
Finally, low-threshold addiction treatment programs, including both medical and behavioural approaches, 
need to be adapted to address the multiples needs of problematic drug users. On the one hand, in the absence of 
specific treatment, problematic cocaine users should have access to a comprehensive array of primary health care 
services, including health promotion, hepatitis A and B vaccination, and screening and treatment for HIV, HCV and 
sexually transmitted infections. Primary care settings should also offer or facilitate access to drug treatment such as 
OST, help to ensure proper registration to universal health coverage, and contribute to efficient mental health 
intervention. On the other hand, there is a crucial need for the development of innovative treatment approaches for 
cocaine users. In the absence of substitution therapy for cocaine, a promising vaccine to hinder the passage of the 
blood-brain barrier by cocaine is being studied (Martell et al., 2009). However, this strategy does not alleviate craving 
nor other acute and sub-acute withdrawal symptoms. Behavioral and pharmacological approaches should be 
developed toward improving the treatment of craving which could prevent relapse, but also reduce distress on 
emotional, cognitive, and physiological levels. Finally, cocaine, alcohol and other drug use should be systematically 
assessed and an individual treatment plan adapted to all patients assessed in OST programs. Multidrug use should 
never be an exclusion criterion in OST programs. 
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